View in EDS

A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia.

Saved in:
Bibliographic Details
Title: A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia.
Authors: Diggin S; Cumulus Neuroscience Ltd., Belfast, United Kingdom., Rueda-Delgado L; Cumulus Neuroscience Ltd., Dublin, Ireland., Buick A; Cumulus Neuroscience Ltd., Belfast, United Kingdom., Dyer JF; Cumulus Neuroscience Ltd., Belfast, United Kingdom., Alexander-Sefre A; Cumulus Neuroscience Ltd., Belfast, United Kingdom., Barbey F; Cumulus Neuroscience Ltd., Dublin, Ireland., Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Muhammed K; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom., Harel BT; Neuroscience Translational Medicine, Takeda Pharmaceuticals, Cambridge, MA, United States., Hansen BJ; Janssen Research & Development, LLC, a Johnson & Johnson Company, Pennsylvania, PA, United States., Tunbridge E; CNS Diseases Research, Boehringer Ingelheim, Biberach, Germany., Lai R; GSK, Stevenage, United Kingdom., Hawellek DJ; Pharma Research and Early Development (pRED), Hoffmann-La Roche Ltd., Basel, Switzerland., Hake AM; Eli Lilly and Company, Indianapolis, IN, United States.; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, United States., Marston H; CNS Diseases Research, Boehringer Ingelheim, Biberach, Germany., Oswal A; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; MRC Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom., Coulthard E; Bristol Medical School, University of Bristol, Bristol, United Kingdom., Pattan V; NHS Forth Valley, Scotland, United Kingdom., Evans V; Re:Cognition Health, Plymouth, Devon, United Kingdom., Gibson S; NHS Forth Valley, Scotland, United Kingdom., Kipps C; Department of Neurology, Wessex Neurological Centre, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Kozak R; Neuroscience Translational Medicine, Takeda Pharmaceuticals, Cambridge, MA, United States., Mannering N; Re:Cognition Health, Plymouth, Devon, United Kingdom.; Re:Cognition Health, Guildford, Surrey, United Kingdom., Moss M; Biogen Inc., Cambridge, MA, United States., Nguyen V; Department of Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States., Ruddock K; NHS Forth Valley, Scotland, United Kingdom., Shinobu LA; Neuro TRC, Bristol Myers Squibb, Cambridge, MA, United States., Toniolo S; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; MRC Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom., Murphy B; Cumulus Neuroscience Ltd., Dublin, Ireland.
Source: Frontiers in digital health [Front Digit Health] 2026 Jun 26; Vol. 8, pp. 1840966. Date of Electronic Publication: 2026 Jun 26 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101771889 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-253X (Electronic) Linking ISSN: 2673253X NLM ISO Abbreviation: Front Digit Health Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42434375
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Diggin+S%22">Diggin S</searchLink>; Cumulus Neuroscience Ltd., Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rueda-Delgado+L%22">Rueda-Delgado L</searchLink>; Cumulus Neuroscience Ltd., Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Buick+A%22">Buick A</searchLink>; Cumulus Neuroscience Ltd., Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dyer+JF%22">Dyer JF</searchLink>; Cumulus Neuroscience Ltd., Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Alexander-Sefre+A%22">Alexander-Sefre A</searchLink>; Cumulus Neuroscience Ltd., Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barbey+F%22">Barbey F</searchLink>; Cumulus Neuroscience Ltd., Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Rowe+JB%22">Rowe JB</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Muhammed+K%22">Muhammed K</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Harel+BT%22">Harel BT</searchLink>; Neuroscience Translational Medicine, Takeda Pharmaceuticals, Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Hansen+BJ%22">Hansen BJ</searchLink>; Janssen Research & Development, LLC, a Johnson & Johnson Company, Pennsylvania, PA, United States.<br /><searchLink fieldCode="AU" term="%22Tunbridge+E%22">Tunbridge E</searchLink>; CNS Diseases Research, Boehringer Ingelheim, Biberach, Germany.<br /><searchLink fieldCode="AU" term="%22Lai+R%22">Lai R</searchLink>; GSK, Stevenage, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hawellek+DJ%22">Hawellek DJ</searchLink>; Pharma Research and Early Development (pRED), Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hake+AM%22">Hake AM</searchLink>; Eli Lilly and Company, Indianapolis, IN, United States.; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, United States.<br /><searchLink fieldCode="AU" term="%22Marston+H%22">Marston H</searchLink>; CNS Diseases Research, Boehringer Ingelheim, Biberach, Germany.<br /><searchLink fieldCode="AU" term="%22Oswal+A%22">Oswal A</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; MRC Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Coulthard+E%22">Coulthard E</searchLink>; Bristol Medical School, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pattan+V%22">Pattan V</searchLink>; NHS Forth Valley, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Evans+V%22">Evans V</searchLink>; Re:Cognition Health, Plymouth, Devon, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gibson+S%22">Gibson S</searchLink>; NHS Forth Valley, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kipps+C%22">Kipps C</searchLink>; Department of Neurology, Wessex Neurological Centre, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kozak+R%22">Kozak R</searchLink>; Neuroscience Translational Medicine, Takeda Pharmaceuticals, Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Mannering+N%22">Mannering N</searchLink>; Re:Cognition Health, Plymouth, Devon, United Kingdom.; Re:Cognition Health, Guildford, Surrey, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Moss+M%22">Moss M</searchLink>; Biogen Inc., Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Nguyen+V%22">Nguyen V</searchLink>; Department of Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Ruddock+K%22">Ruddock K</searchLink>; NHS Forth Valley, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Shinobu+LA%22">Shinobu LA</searchLink>; Neuro TRC, Bristol Myers Squibb, Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Toniolo+S%22">Toniolo S</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; MRC Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Murphy+B%22">Murphy B</searchLink>; Cumulus Neuroscience Ltd., Dublin, Ireland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101771889%22">Frontiers in digital health</searchLink> [Front Digit Health] 2026 Jun 26; Vol. 8, pp. 1840966. <i>Date of Electronic Publication: </i>2026 Jun 26 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101771889 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2673-253X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222673253X%22">2673253X </searchLink><i>NLM ISO Abbreviation: </i>Front Digit Health <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42434375
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fdgth.2026.1840966
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1840966
    Titles:
      – TitleFull: A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Diggin S
      – PersonEntity:
          Name:
            NameFull: Rueda-Delgado L
      – PersonEntity:
          Name:
            NameFull: Buick A
      – PersonEntity:
          Name:
            NameFull: Dyer JF
      – PersonEntity:
          Name:
            NameFull: Alexander-Sefre A
      – PersonEntity:
          Name:
            NameFull: Barbey F
      – PersonEntity:
          Name:
            NameFull: Rowe JB
      – PersonEntity:
          Name:
            NameFull: Muhammed K
      – PersonEntity:
          Name:
            NameFull: Harel BT
      – PersonEntity:
          Name:
            NameFull: Hansen BJ
      – PersonEntity:
          Name:
            NameFull: Tunbridge E
      – PersonEntity:
          Name:
            NameFull: Lai R
      – PersonEntity:
          Name:
            NameFull: Hawellek DJ
      – PersonEntity:
          Name:
            NameFull: Hake AM
      – PersonEntity:
          Name:
            NameFull: Marston H
      – PersonEntity:
          Name:
            NameFull: Oswal A
      – PersonEntity:
          Name:
            NameFull: Coulthard E
      – PersonEntity:
          Name:
            NameFull: Pattan V
      – PersonEntity:
          Name:
            NameFull: Evans V
      – PersonEntity:
          Name:
            NameFull: Gibson S
      – PersonEntity:
          Name:
            NameFull: Kipps C
      – PersonEntity:
          Name:
            NameFull: Kozak R
      – PersonEntity:
          Name:
            NameFull: Mannering N
      – PersonEntity:
          Name:
            NameFull: Moss M
      – PersonEntity:
          Name:
            NameFull: Nguyen V
      – PersonEntity:
          Name:
            NameFull: Ruddock K
      – PersonEntity:
          Name:
            NameFull: Shinobu LA
      – PersonEntity:
          Name:
            NameFull: Toniolo S
      – PersonEntity:
          Name:
            NameFull: Murphy B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 06
              Text: 2026 Jun 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2673-253X
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: Frontiers in digital health
              Type: main
ResultId 1